Discover
ZLAB
Zai Lab Limited
25.70
2 x 13.12
2 x 23.88
bid
ask
-
0.11
0.43%
2 @ 07:30 PM
25.70 +0.00 (0.00%)
| Ytd | 45.69% | |
| 1y | -22.12% |
25.61
day range
27.10
16.30
52 week range
34.44
| Open | 26.26 | Prev Close | 25.81 | Low | 25.61 | High | 27.10 | Mkt Cap | 2.89B |
| Vol | 887.48K | Avg Vol | 987.52K | EPS | -1.70 | P/E | N/A | Forward P/E | -12.18 |
| Beta | 0.83 | Short Ratio | 6.57 | Inst. Own | 38.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 22.99 | 200-d Avg | 20.02 | 1yr Est | 33.14 |
| Income Statement | |||
| Total Revenue | 106.31M | ||
| Revenues (USD) | 106.31M | ||
| Cost of Revenue | 48.16M | ||
| Gross Profit | 58.15M | ||
| Operating Expenses | 129.35M | ||
| Research and Development Expense | 61.77M | ||
| Selling, General and Administrative Expense | 72.87M | ||
| Operating Income | -71.20M | ||
| Interest Expense | 1.59M | ||
| Income Tax Expense | -1.02M | ||
| Net Income | -50.82M | ||
| Net Income Common Stock | -50.82M | ||
| Net Income Common Stock (USD) | -50.82M | ||
| Consolidated Income | -50.82M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -50.26M | ||
| Earning Before Interest & Taxes (USD) | -50.26M | ||
| Weighted Average Shares | 1.12B | ||
| Weighted Average Shares Diluted | 1.12B | ||
| Balance Sheet | |||
| Cash and Equivalents | 707.52M | ||
| Cash and Equivalents (USD) | 707.52M | ||
| Investments | 14.51M | ||
| Investments Current | 13.40M | ||
| Investments Non-Current | 1.12M | ||
| Trade and Non-Trade Receivables | 69.60M | ||
| Current Assets | 914.04M | ||
| Property, Plant & Equipment Net | 62.59M | ||
| Total Assets | 1.07B | ||
| Debt Current | 243.13M | ||
| Total Debt | 254.58M | ||
| Current Liabilities | 428.58M | ||
| Debt Non-Current | 11.45M | ||
| Total Liabilities | 467.76M | ||
| Accumulated Retained Earnings (Deficit) | -2.73B | ||
| Accumulated Other Comprehensive Income | 214.00K | ||
| Shareholders Equity | 607.04M | ||
| Shareholders Equity (USD) | 607.04M | ||
| Assets Non-Current | 160.76M | ||
| Total Debt (USD) | 254.58M | ||
| Deferred Revenue | 27.50M | ||
| Goodwill and Intangible Assets | 88.66M | ||
| Inventory | 90.89M | ||
| Liabilities Non-Current | 39.17M | ||
| Trade and Non-Trade Payables | 136.69M | ||
| Tax Assets | 4.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.84M | ||
| Net Cash Flow from Financing | 18.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -43.79M | ||
| Capital Expenditure | -1.27M | ||
| Issuance (Purchase) of Equity Shares | 946.00K | ||
| Issuance (Repayment) of Debt Securities | 19.96M | ||
| Net Cash Flow from Investing | -1.42M | ||
| Net Cash Flow from Operations | -63.41M | ||
| Effect of Exchange Rate Changes on Cash | 2.33M | ||
| Share Based Compensation | 11.94M | ||